July - December 2009
Companies are listed in alphabetical order
1 July – 31 December 2009
- Abbott Australasia
64k - Actelion 20k
- Alcon Pharmaceuticals 403k
- Allergan 78k
- AMGEN Australia 169k
- AstraZeneca 363k
- Baxter Healthcare 58k
- Bayer Australia 70k
- Biogen Idec Australia 142k
- Boehringer Ingelheim 295k
- Bristol-Myers Squibb Australia 125k
- Celgene Pty Ltd 82k
- CSL Limited 60k
- Eli Lilly Australia 731k
- Genzyme Australasia Pty Ltd 38k
- Gilead Sciences 43k
- GlaxoSmithKline Australia 536k
- Innovex 11k
- iNova Pharmaceuticals 22k
- Ipsen 55k
- Janssen-Cilag 687k
- Lundbeck 40k
- Merck Serono 46k
- Merck Sharp & Dohme Australia 128k
- Mundipharma 16k
- Norgine 28k
- Novartis Pharmaceuticals 574k
- Novo Nordisk 247k
- Nycomed 99k
- Pfizer Australia 381k
- Roche Products 200k
- sanofi-aventis 492k
- Schering-Plough 496k
- Servier Laboratories 182k
- Shire Australia 21k
- Smith & Nephew Pty Ltd
15k - Solvay Pharmaceuticals 59k
- Stiefel Laboratories 104k
- UCB Pharma 97k
- Wyeth Australia 115k
Previous Educational Event Reports
Page updated: December 2011